Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ionis Pharmaceuticals
Ionis Pharmaceuticals
Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Forbes
Fri, 04/20/18 - 09:48 am
Biogen
Ionis Pharmaceuticals
drug development
R&D
Ionis to get up to $300 mln from licensing deal with AstraZeneca
Yahoo/Reuters
Mon, 04/9/18 - 09:06 am
Ionis Pharmaceuticals
AstraZeneca
fatty liver disease
Why Pfizer's Big Win Is Bad News for Alnylam and Ionis
Yahoo/Motley Fool
Mon, 04/2/18 - 03:07 pm
Pfizer
Alnylam
Ionis Pharmaceuticals
tafamidis
inotersen
Patisiran
Pfizer's rare heart disease drug succeeds in late-stage study
Yahoo/Reuters
Fri, 03/30/18 - 09:35 am
Pfizer
clinical trials
tafamidis
transthyretin cardiomyopathy
rare disease
Alnylam
Ionis Pharmaceuticals
Ionis Sends Nerve Drug to Spinout Akcea as Battle with Alnylam Looms
Xconomy
Thu, 03/15/18 - 11:09 am
Ionis Pharmaceuticals
Akcea
Alnylam
transthyretin amyloidosis
inotersen
IONIS-TTR-Lrx
Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
Endpoints
Thu, 03/1/18 - 11:48 pm
Roche
Ionis Pharmaceuticals
clinical trials
Huntington's disease
IONIS-HTT Rx
AstraZeneca hauls kidney disease drug into the clinic after handing Ionis $30M in cash, $300M in milestones
Endpoints
Tue, 02/20/18 - 11:07 am
AstraZeneca
kidney disease
Ionis Pharmaceuticals
AZD2373
antisense
Will 2018 Be Ionis Pharmaceuticals, Inc.'s Best Year Yet?
Motley Fool
Sat, 01/13/18 - 10:43 pm
Ionis Pharmaceuticals
SMA
Spinraza
Biogen, Ionis looking for new SMA drugs following Spinraza's success
BioPharma Dive
Wed, 12/20/17 - 11:05 pm
Biogen
Ionis Pharmaceuticals
SMA
Spinraza
Roche snaps up Huntington's drug on positive data
BioPharma Dive
Thu, 12/14/17 - 09:14 am
Roche
Huntington's disease
Ionis Pharmaceuticals
IONIS-HTTRx
J&J goes back to Ionis for its second experimental pill for a GI autoimmune disease
Endpoints
Thu, 11/16/17 - 11:08 am
JNJ
Ionis Pharmaceuticals
autoimmune disease
IONIS-JBI2-2.5Rx
antisense
NEJM publishes Phase III results for Biogen/Ionis’ Spinraza
GoinPharma
Mon, 11/6/17 - 08:56 am
Biogen
Ionis Pharmaceuticals
Spinraza
clinical trials
spinal muscular atrophy
SMA
Alnylam outshines Ionis with RNAi drug
BioPharma Dive
Sat, 11/4/17 - 08:40 am
Alnylam
Ionis Pharmaceuticals
RNAi
Sanofi
Patisiran
amyloidosis
3 Drug Stocks Hitting 52-Week Highs
Motley Fool
Tue, 10/17/17 - 09:42 am
Biogen
Halozyme Therapeutics
Ionis Pharmaceuticals
Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug
GoinPharma
Mon, 10/16/17 - 09:37 pm
Alzheimer's disease
Ionis Pharmaceuticals
IONIS-MAPTRx
antisense
Could This Drug Help Ionis Stock Recover From a Disappointing 2016?
Motley Fool
Sun, 03/12/17 - 10:49 am
Ionis Pharmaceuticals
volanersorsen
familial chylomicronemia syndrome
Why Spinraza Is The Only Exciting Thing About Ionis Pharmaceuticals
Yahoo/Benzinga
Sat, 01/7/17 - 12:55 pm
Ionis Pharmaceuticals
Spinraza
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi
The 3 Best Biotech Stocks for 2017
Motley Fool
Fri, 12/9/16 - 09:23 am
biotech
biotech stocks
Celgene
Ionis Pharmaceuticals
Kite Pharma
Here's Why Biogen Should Buy Ionis Pharmaceuticals
Motley Fool
Sat, 10/29/16 - 01:18 pm
Biogen
Ionis Pharmaceuticals
R&D
George Scangos
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »